Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Phaeochromocytoma
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Diagnosis''' == * Biochemical ** Need to confirm elevated levels of catecholamines and their metabolites in body fluids. The exact profiles vary; tumours have different characteristics depending on their expression of synthetic and degradative enzymes. ** Testing rationale *** Plasma metanephrines/normetanephrines: sensitivity 99%, specificity 85% **** Drawn in supine position, and after an overnight fast, avoiding caffeine and nicotine *** 24-hour urine catecholamines and metabolites: specificity 99% **** Considered positive when total metanephrines or any single catecholamine fraction is elevated above its cut-off value. This maintains high specificity and yields a sensitivity of about 88%. *** Given that phaeochromocytoma is a rare diagnosis within a large pool of hypertensive patients, false-positives are a real problem, and specificity is crucial. It has been estimated that false-positives outnumber true positives by up to 30:1 when plasma metanephrines are used as screening. ** Drugs and conditions that can cause elevated metanephrines: *** Sympathomimetics *** Phenoxybenzamine *** Paracetamol *** Psychotropic drugs including TCAs *** Major physical or psychological stressors ** Approach *** Start with serum metanephrines *** If positive, test urine *** Clonidine suppression testing (give 0.3mg oral clonidine) can be used but is uncommonly needed * Anatomical localisation/staging ** CT or MRI can be used - CT is often more useful, but MRI is slightly more sensitive *** CT - characteristic - heterogenous with higher attenuation. All phaeos have HU > 10. *** MRI - bright on T2 ** Scintigraphy with (131)I or (123)I-labeled metaiodobenzylguanidine (MIBG) can be performed when multifocal or malignant disease is suspected *** Highly specific, but sensitivity only 77-90% ** PET (F-DOPA) which somehow uses DOTATATE is developing as superior to MIBG, but apparently isn't widely available yet * Check for genetic syndromes * Histopathological ** PASS score - composite of capsular or vascular invasion, mitotic rate, necrosis ** GAPP - phaeos and paragangliomas - combines histopathological and clinical criteria - probably the more favoured score now
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Phaeochromocytoma
(section)
Add topic